CLINICAL_TRIALS
trial_result
· 2013-11-04
Clinical Trial Update: SB-681323 In Subjects With Rheumatoid Arthritis [Phase 2]
Summary
A Phase 2 study of SB-681323 in rheumatoid arthritis has completed; the document does not include efficacy or safety results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED